Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2022
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
W Kimryn Rathmell, R Bryan Rumble, Peter J Van Veldhuizen, et al.
Nature Communications
|
December 13, 2025
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling
Michael S Sturdivant, Andrew S Truong, Mi Zhou, et al.
British Journal of Cancer
|
March 12, 2022
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
Tracy L Rose, William H Weir, Gregory M Mayhew, et al.
British Journal of Cancer
|
July 23, 2021
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
Tracy L Rose, William H Weir, Gregory M Mayhew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2021
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer
Tracy L Rose, Michael R Harrison, Allison M Deal, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
December 31, 2016
Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
Tracy L Rose, Allison M Deal, Sylvain Ladoire, et al.
Nature Communications
|
May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
The Journal of Clinical Investigation
|
January 16, 2024
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
Atsushi Okato, Takanobu Utsumi, Michela Ranieri, et al.
Eclinicalmedicine
|
June 12, 2023
Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study
Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, et al.
Clinical Genitourinary Cancer
|
March 10, 2020
Pilot Study of [<sup>18</sup>F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)
Patrick J Eulitt, Ersan Altun, Arif Sheikh, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2022
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
W Kimryn Rathmell, R Bryan Rumble, Peter J Van Veldhuizen, et al.
Nature Communications
|
December 13, 2025
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling
Michael S Sturdivant, Andrew S Truong, Mi Zhou, et al.
British Journal of Cancer
|
March 12, 2022
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
Tracy L Rose, William H Weir, Gregory M Mayhew, et al.
British Journal of Cancer
|
July 23, 2021
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
Tracy L Rose, William H Weir, Gregory M Mayhew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2021
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer
Tracy L Rose, Michael R Harrison, Allison M Deal, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
December 31, 2016
Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
Tracy L Rose, Allison M Deal, Sylvain Ladoire, et al.
Nature Communications
|
May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
The Journal of Clinical Investigation
|
January 16, 2024
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
Atsushi Okato, Takanobu Utsumi, Michela Ranieri, et al.
Eclinicalmedicine
|
June 12, 2023
Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study
Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, et al.
Clinical Genitourinary Cancer
|
March 10, 2020
Pilot Study of [<sup>18</sup>F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)
Patrick J Eulitt, Ersan Altun, Arif Sheikh, et al.
Page
of 7